Application of a rapid and selective method for the simultaneous determination of protease inhibitors, lopinavir and ritonavir in human plasma by UPLC–ESI-MS/MS for bioequivalence study in Indian subjects

This publication has 38 references indexed in Scilit:

• Determination of lopinavir and ritonavir in blood plasma, seminal plasma, saliva and plasma ultra‐filtrate by liquid chromatography/tandem mass spectrometry detection
  Rapid Communications in Mass Spectrometry, 2008
• Determination of lopinavir cerebral spinal fluid and plasma ultrafiltrate concentrations by liquid chromatography coupled to tandem mass spectrometry
  Journal of Pharmaceutical and Biomedical Analysis, 2007
• Electrospray tandem mass spectroscopic characterisation of 18 antiretroviral drugs and simultaneous quantification of 12 antiretrovirals in plasma
  Rapid Communications in Mass Spectrometry, 2007
• Simultaneous determination of 8 HIV protease inhibitors in human plasma by isocratic high-performance liquid chromatography with combined use of UV and fluorescence detection: Amprenavir, indinavir, atazanavir, ritonavir, lopinavir, saquinavir, nelfinavir and M8-nelfinavir metabolite
  Journal of Chromatography B, 2007
• Lopinavir/rotinavir: Appraisal of its use in HIV therapy
  Drugs of Today, 2007
• Plasma and cerebrospinal pharmacokinetics and pharmacodynamics in subjects taking lopinavir/ritonavir
  AIDS, 2006
• Determination of anti-HIV drug concentration in human plasma by MALDI-TOF/TOF
  Journal of Chromatography B, 2006
• Simultaneous determination of HIV protease inhibitors amprenavir, atazanavir, indinavir, lopinavir, nelfinavir, ritonavir and saquinavir in human plasma by high-performance liquid chromatography-tandem mass spectrometry
  Journal of Chromatography B, 2005
• Determination of saquinavir and ritonavir in human plasma by reversed-phase high-performance liquid chromatography and the analytical error function
  Journal of Pharmaceutical and Biomedical Analysis, 2004
• Lopinavir/Ritonavir
  Drugs, 2003